DECIPHERA PHARMACEUTICALS IN's ticker is DCPH and the CUSIP is 24344T101. A total of 165 filers reported holding DECIPHERA PHARMACEUTICALS IN in Q3 2020. The put-call ratio across all filers is 1.08 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,613,009 | -18.4% | 126,809 | -9.7% | 0.00% | 0.0% |
| Q2 2023 | $1,976,409 | +11.4% | 140,370 | +22.2% | 0.00% | 0.0% |
| Q1 2023 | $1,774,432 | -10.2% | 114,850 | -4.8% | 0.00% | 0.0% |
| Q4 2022 | $1,975,000 | -25.8% | 120,592 | -16.2% | 0.00% | 0.0% |
| Q3 2022 | $2,662,000 | +175.3% | 143,836 | +95.5% | 0.00% | – |
| Q2 2022 | $967,000 | +141.8% | 73,567 | +724.6% | 0.00% | – |
| Q1 2021 | $400,000 | -84.3% | 8,921 | -80.1% | 0.00% | -100.0% |
| Q4 2020 | $2,555,000 | +99.3% | 44,762 | +79.0% | 0.00% | 0.0% |
| Q3 2020 | $1,282,000 | -14.2% | 25,001 | -0.1% | 0.00% | 0.0% |
| Q2 2020 | $1,495,000 | +433.9% | 25,031 | +455.6% | 0.00% | – |
| Q4 2019 | $280,000 | -70.9% | 4,505 | -81.8% | 0.00% | – |
| Q3 2018 | $961,000 | -16.0% | 24,807 | -14.7% | 0.00% | -100.0% |
| Q2 2018 | $1,144,000 | – | 29,066 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Leaf Venture Partners, L.L.C. | 1,209,571 | $11,213,000 | 5.53% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 5,580,456 | $51,731,000 | 1.16% |
| ARMISTICE CAPITAL, LLC | 5,836,000 | $54,100,000 | 1.05% |
| Pinz Capital Management, LP | 165,835 | $1,537,000 | 0.96% |
| Sunesis Advisors, LLC | 96,299 | $893,000 | 0.52% |
| Redmile Group, LLC | 664,817 | $6,163,000 | 0.19% |
| PDT Partners, LLC | 222,343 | $2,061,000 | 0.18% |
| Bayesian Capital Management, LP | 41,900 | $388,000 | 0.06% |
| Laurion Capital Management LP | 459,290 | $4,258,000 | 0.05% |
| Hennion & Walsh Asset Management, Inc. | 101,643 | $942,000 | 0.05% |